New York State Common Retirement Fund Eye Point Pharmaceuticals, Inc. Transaction History
New York State Common Retirement Fund
- $74.9 Billion
- Q3 2025
A detailed history of New York State Common Retirement Fund transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 12,214 shares of EYPT stock, worth $144,735. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,214
Previous 10,414
17.28%
Holding current value
$144,735
Previous $97,000
74.23%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding EYPT
# of Institutions
167Shares Held
68.8MCall Options Held
421KPut Options Held
401K-
Cormorant Asset Management, LP Boston, MA8.33MShares$98.7 Million18.35% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.19MShares$73.4 Million2.57% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.56MShares$65.9 Million0.13% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.42MShares$52.3 Million0.12% of portfolio
-
Franklin Resources Inc San Mateo, CA4.17MShares$49.4 Million0.02% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $404M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...